Neurol. praxi. 2014;15(1):39-42

Transcranial sonography with Parkonson΄s syndrome

MUDr. Monika Jelínková1,3, doc. MUDr. David Školoudík, Ph.D., FESO1,2, MUDr. Petra Bártová, Ph.D.1, prof. MUDr. Petr Kaňovský, CSc.2
1 Neurologická klinika FN Ostrava
2 Neurologická klinika LF UP a FN Olomouc
3 Neurologické oddělení Nemocnice s poliklinikou Karviná Ráj

The authors present possibilities of the use of transcranial sonography of brain parenchyma in patients with movement disorders. In the article is described the technique of examination, technical parameters and sonographic findings in patients with Parkinson´s disease, multiple-system atrophy, progressive supranuclear palsy and corticobasal degeneration. supranuclear palsy, corticobasal degeneration, substantia nigra, nucleus lenticularis, nucleus caudate, brainstem raphe.

Keywords: movement disorders, transcranial sonography of brain parenchyma, Parkinson´s disease, multiple system atrophy, progressive

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jelínková M, Školoudík D, Bártová P, Kaňovský P. Transcranial sonography with Parkonson΄s syndrome. Neurol. praxi. 2014;15(1):39-42.
Download citation

References

  1. Aaslid R, Eden A, Ringelstein EB. Eds. Transcranial Doppler Sonography. Wien: Springer, 1986. Go to original source...
  2. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson´s disease visualized by transcranial color-coded real-time sonography. Neurology 1995; 45: 182-184. Go to original source... Go to PubMed...
  3. Naumann H, Becker G, Toyka KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996; 47: 1284-1290. Go to original source... Go to PubMed...
  4. Postert T, Lack B, Kuhn W. Jergas M, Andrich J, Braun B, Przuntek H, Sprengelmeyer R, Agelink M, Büttner T. Basal ganglia alterations and brain atrophy in Huntington´s disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 1999; 67: 457-462. Go to original source... Go to PubMed...
  5. Walter U, Behnke S, Eyding J, Niehaus L, Postert T, Seidel G, Berg D. Transcranial brain parenchyma sonography in movement disorders: State of the art. Ultrasound Med Biol 2007; 33: 15-25. Go to original source... Go to PubMed...
  6. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW. Vulnerability of the nigrostriatal systém as detected by transcranial ultrasound. Neurology 1999; 53: 1026-1031. Go to original source... Go to PubMed...
  7. Becker G, Struck M, Bogdahn U, Becker T. Echogenicity of the brainstem raphe in patiens with major depression. Psychiatry Res 1994; 55: 75-84. Go to original source... Go to PubMed...
  8. Berg D, Supprian T, Hofmann E, Zeiler B, Jäger A, Lange KW, Reiners K, Becker T, Becker G. Depression in Parkinson ´s disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol 1999; 246: 1186-1193. Go to original source... Go to PubMed...
  9. Postert T, Eyding J, Berg D, Przuntek H, Becker G, Finger M, Schöls L. Transcranial sonography in spinocerebellar ataxia type 3. J Neural Transm 2004; 68(Suppl.): 123-133. Go to original source... Go to PubMed...
  10. Seidel G, Kaps M, Gerriets T, Hutzelmann A. Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 1995; 5: 105-108. Go to original source... Go to PubMed...
  11. Walter U, Dressler D, Wolters A, Probst T, Grossmann A, Benecke R. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy. Neurology 2004; 63: 504-509. Go to original source... Go to PubMed...
  12. Naumann M, Becker G, Toyka KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996; 47: 1284-1290. Go to original source... Go to PubMed...
  13. Berg D, Grote C, Rausch WD, Mäurer M, Wesemann W, Riederer P, Becker G. Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999c; 25: 901-904. Go to original source... Go to PubMed...
  14. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson´s disease and its relation to clinical findings. J Neurol 2001; 8: 684-689. Go to original source... Go to PubMed...
  15. Berg D, Siefker C, Ruprecht-Dorfler P, Becker G. Relationship of substantia nigra echogenicity and motor fiction in elderly subjects. Neurology 2001a; 56: 13-17. Go to original source... Go to PubMed...
  16. Iova A, Garmashov A, Androuchtchenko N, Kehrer M, Berg D, Becker G, Garmashov Y. Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson´s disease. J Neurol 2004; 251: 1451-1454. Go to original source... Go to PubMed...
  17. Fearnly JM, Lees AJ. Ageing and Parkinson´s disease: Substantia nigra regional selectivity. Brain 1991; 114: 2283-2301. Go to original source... Go to PubMed...
  18. Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D. Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 2004; 19: 1445-1449. Go to original source... Go to PubMed...
  19. Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H. Detection of presymptomatic Parkinson´s disease: Combining smell tests, transcranial sonography, and SPECT. Mov Disord 2004; 19: 1196-1202. Go to original source... Go to PubMed...
  20. Behnke S, Berg D, Naumann M, Becker G. Differentiation of Parkinson´s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 2005; 76: 423-425. Go to original source... Go to PubMed...
  21. Berg D, Naumann M, Hoggenmuller U. Differences of echogenicity and T2 relaxation time of the nucleus lentiformis in MSA and PSP as compared to Parkinson´s disease. Mov Disord 2000; 15(Suppl 3): 206-207.
  22. Niehaus L, Savyer N, Weber U, Hertel R. Brain parenchyma sonography in patiens with Essentials tremor and Parkinson´s disease. Cerebrovasc Dis 2004; 17(Suppl 4): 3.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.